XOMA Royalty Corporation Depositary Shs Repr 1/1000th 8.375% Cum Conv Perp Red Pfd Rg Shs Series B XOMAO 深 滬
等待開盤 03-26 09:30:00 美东时间
25.42
+0.010
+0.04%
華盛通- 最 高25.42
- 今 開25.42
- 成交量 327股
- 最 低 25.42
- 昨 收 25.41
- 總市值 4067.20万
- 52周最高 25.6199
- 市盈率 靜 --
- 換手率 0.02%
- 52周最低 22.1624
- 委 比 -66.80%
- 總股本 160.00万
- 歷史最高 25.6199
- 量 比 0.13
- 振 幅 0.00%
- 歷史最低 14.0698
- 每 手 1
- 風險率 0.66%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Pyxis Oncology, Inc. reported updates on its lead candidate MICVO, including completion of target enrollment in a Phase 1 monotherapy study for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) in the first quarter of 2026. The company also announced updated data expected in mid-2026, which will include patients treated with modified weight-based dosing. Additionally, Pyxis Oncology shared financial results for 2025, includin...
03-23 11:00
XOMA Royalty Corporation (XOMA) Gets a Buy from H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on XOMA Royalt...
03-20 18:36
HC Wainwright & Co. Reiterates Buy on XOMA Royalty, Maintains $97 Price Target
HC Wainwright & Co. analyst Joseph Pantginis reiterates XOMA Royalty (NASDAQ:XOMA) with a Buy and maintains $97 price target.
03-20 18:30
XOMA Royalty Declares Quarterly Preferred Stock Dividends
XOMA Royalty Corporation announced cash dividends for its Series A and Series B Cumulative Preferred Stock. Series A holders will receive $0.53906 per share, while Series B depositary shares will receive $0.52344 per share. Payments are scheduled for April 15, 2026, to holders of record as of April 2, 2026. XOMA Royalty specializes in acquiring future economic rights from biotech therapies, providing non-dilutive funding to sellers and potential ...
03-18 20:30
Earnings Scheduled For March 18, 2026
Companies Reporting Before The Bell • SailPoint (NASDAQ:SAIL) is estimated to r...
03-18 19:11
XOMA Q4 EPS $0.26 Beats $(0.15) Estimate, Sales $13.757M Beat $11.049M Estimate
XOMA (NASDAQ:XOMA) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $(0.15) by 267.74 percent. This is a 157.78 percent increase over losses of $(0.45) per share from the same
03-18 18:34
BRIEF-XOMA FY EPS USD 1.46
BRIEF-XOMA FY EPS USD 1.46 Mar 18 (Reuters) - XOMA FY operating expenses USD 40.765 million. FY net income USD 31.712 million FY operating income USD 11.384 million
03-18 18:00
XOMA FY Earnings Preview
XOMA (XOMA) is scheduled to announce FY earnings results on Wednesday, March 18th, before market open.The consensus EPS Estimate is $1.17 (+170.9% Y/Y) and the consensus Revenue Estimate is $49.42M (+...
03-18 03:25
XOMA Royalty schedules webcast to discuss fourth-quarter and full-year results
XOMA Royalty schedules webcast to discuss fourth-quarter and full-year results XOMA Royalty will report fourth-quarter and full-year 2025 financial results on March 18, 2026. The company will host a webcast on March 18, 2026 at 8:00 am Eastern Time. The webcast will be available at XOMA Royalty News
03-12 18:30
XOMA Royalty to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
XOMA Royalty Corporation will announce its fourth-quarter and full-year 2025 financial results on March 18, 2026, followed by a webcast at 8:00 am Eastern Time to discuss the results and provide a business update. The webcast will be accessible on the company's "News & Events" page, with a replay available for 30 days. XOMA Royalty is a biotech royalty aggregator that acquires potential future economics associated with therapeutic candidates, pro...
03-12 10:30
